Literature DB >> 11948552

Insulin aggregation and asymmetric transport across human bronchial epithelial cell monolayers (Calu-3).

Isabelle Pezron1, Ranjana Mitra, Dahnanjay Pal, Ashim K Mitra.   

Abstract

The purpose of this work was to elucidate the transport pathways of zinc insulin across the Calu-3 cell monolayer, an in vitro model of the human airway epithelium. Calu-3 cells grown in liquid-covered conditions formed a confluent monolayer with a high transepithelial electrical resistance value of 1000 +/- 150 Omega small middle dot cm(2). The cell monolayer was characterized by a low mannitol permeability of 4.7 +/- 0.5 10(-7)cm/s. Transport of zinc insulin (donor concentration 1 U/mL) in Dulbecco's modified phosphate buffer saline at 37 degrees C was found to be higher in the basolateral (BL) to apical (AP) (P(app) = 3.0 +/- 0.2 10(-8) cm/s), than in the AP to BL direction (P(app) = 0.41 +/- 0.02 10(-8) cm/s). P-glycoprotein efflux or specific enzymatic degradation did not appear to contribute toward this asymmetric transport. Insulin receptors, though apparently more abundant on the BL side than on the AP side of Calu-3 cells, did not mediate the direction-dependent transport of insulin. However, transport of a monomeric human insulin analog, Asp(B10)des(B28-30), across the Calu-3 cell monolayer was similar in both directions (BL to AP and AP to BL). The corresponding permeability, P(app) = 2.9 +/- 0.2 10(-8) cm/s, was not significantly different from the permeability of zinc insulin in the BL to AP direction. The paracellular pathway seems to play a major role in the insulin transport across the Calu-3 cell monolayers. We hypothesize that the transport of zinc insulin oligomers is restricted at the AP surface by the presence of the tight junctional complexes. From the BL side, oligomers may undergo dissociation in the intercellular space and diffuse readily as monomers to the AP surface of the membrane. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:1135-1146, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948552     DOI: 10.1002/jps.10114

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Evidence for LHRH-receptor expression in human airway epithelial (Calu-3) cells and its role in the transport of an LHRH agonist.

Authors:  Kavitha Koushik; Nagesh Bandi; Sneha Sundaram; Uday B Kompella
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

2.  Passive asymmetric transport of hesperetin across isolated rabbit cornea.

Authors:  Ramesh Srirangam; Soumyajit Majumdar
Journal:  Int J Pharm       Date:  2010-05-09       Impact factor: 5.875

3.  Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier.

Authors:  Christopher I Grainger; Leona L Greenwell; David J Lockley; Gary P Martin; Ben Forbes
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

4.  Technosphere insulin: defining the role of Technosphere particles at the cellular level.

Authors:  Robert Angelo; Kathleen Rousseau; Marshall Grant; Andrea Leone-Bay; Peter Richardson
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

5.  Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium.

Authors:  Thomas C Sutherland; Paola Quattroni; Rachel M Exley; Christoph M Tang
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

6.  Transport of HIV-protease inhibitors across 1 alpha,25di-hydroxy vitamin D3-treated Calu-3 cell monolayers: modulation of P-glycoprotein activity.

Authors:  Jignesh Patel; Dhananjay Pal; Veena Vangal; Mohit Gandhi; Ashim L Mitra
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

7.  Pulmonary delivery of low molecular weight heparins.

Authors:  Tianzhi Yang; Fatima Mustafa; Shuhua Bai; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

8.  Insulin-induced electrophysiology changes in human pleura are mediated via its receptor.

Authors:  V K Kouritas; M Ioannou; C N Foroulis; N Desimonas; K Evaggelopoulos; K I Gourgoulianis; P A Molyvdas; C Hatzoglou
Journal:  Exp Diabetes Res       Date:  2010-08-12

9.  Permeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In Vitro.

Authors:  Claudia Meindl; Sandra Stranzinger; Neira Dzidic; Sharareh Salar-Behzadi; Stefan Mohr; Andreas Zimmer; Eleonore Fröhlich
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

Review 10.  Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles.

Authors:  Mohammad A Alsenaidy; Nishant K Jain; Jae H Kim; C Russell Middaugh; David B Volkin
Journal:  Front Pharmacol       Date:  2014-03-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.